in 2019, Medicinal Cannabis Industry Australia (MCIA)
is the peak industry organisation for Australia’s licensed
medicinal cannabis industry, with a focus
on building an industry that enhances wellbeing through facilitating
access to quality Australian medicinal cannabis products for
Australian and global patients.
The Medicinal Cannabis Industry Australia, (MCIA) is launching the inaugural
ACannabis Conference to help define and shape the future of the Australian
Medicinal Cannabis industry.
The event will draw together all facet of the industries ecosystem to connect,
engage and build a framework to support patients’ well-being, enable best practice,
and strengthen growth for the industry.
Medicinal Cannabis Industry Australia (MCIA) is pleased that Minister
Hunt has committed to acting on all 26 recommendations in the
McMillan Report on the review of the Narcotic
Drugs Act 1967, but
seeks further engagement with the Government in relation to the
implementation of the report’s recommendations to ensure that the
intended outcomes are delivered.
The Medicinal Cannabis Industry Australia today welcomed the Government’s response to the Narcotic Drugs Act 1967 review which provides commitment to improving the efficiency of the Government regulator and better access to medicinal cannabis products for patients.
Around 70 members of parliament, government representatives, patient advocacy groups and industry participants gathered for the launch of the medicinal cannabis industry’s peak industry body – Medicinal Cannabis Industry Australia (MCIA).
Australia’s medicinal cannabis industry licensees are coming together to form a national advocacy body to support the fledgling industry achieve health and economic benefits for Australians.
Launched by Health Minister Greg Hunt in Canberra today, with support from Labor and the Greens, Medicinal Cannabis Industry Australia (MCIA) will be a strong voice for the sector which is committed to producing the highest quality medicinal cannabis products for patients.